Aurora Cannabis (ACB) Research & Development (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of Research & Development data on file, last reported at $934363.4 in Q4 2025.

• Research & Development for Q4 2025 came in at $934363.4, up 40.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.7 million (up 3.16% YoY), and the FY2025 annual result was $2.6 million, down 3.36% from the prior year.
• Research & Development advanced to $934363.4 in Q4 2025 per ACB's latest filing, from $656878.0 in the prior quarter.
• Over five years, Research & Development peaked at $2.9 million in Q3 2021 and troughed at $547079.4 in Q1 2025.
• A 5-year average of $1.2 million and a median of $718181.4 in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2021 and 2022: Research & Development soared 50.39% in 2021, then slumped 69.24% in 2022.
• A 5-year view of Research & Development shows it stood at $1.3 million in 2021, then slumped by 45.48% to $702814.6 in 2022, then decreased by 18.27% to $574406.8 in 2023, then rose by 15.78% to $665023.9 in 2024, then surged by 40.5% to $934363.4 in 2025.
• Business Quant data shows ACB's Research & Development at $934363.4 in Q4 2025, $656878.0 in Q3 2025, and $598299.7 in Q2 2025.